Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss study NBC News Top Stories Berkeley Lovelace Jr. 8 July 2024 at 11:39 Tirzepatide, the active ingredient in Eli Lillyβs Mounjaro and Zepbound, leads to more weight loss than semaglutide, the active ingredient in Novo Nordiskβs Ozempic and Wegovy, new research suggests. Β© Eli Lilly; Novo NordiskZepbound and Wegovy injection pens. Β© Eli Lilly; Novo NordiskZepbound and Wegovy injection pens.
FDA approves Alzheimerβs treatment that has been shown to slow decline in memory NBC News Top Stories Berkeley Lovelace Jr. 2 July 2024 at 14:28 The FDA approved a new Alzheimerβs drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities. Β© Eli LillyKisunla.